117 related articles for article (PubMed ID: 8263156)
41. Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT.
Lefebvre H; Compagnon P; Contesse V; Delarue C; Thuillez C; Vaudry H; Kuhn JM
J Clin Endocrinol Metab; 2001 Oct; 86(10):5001-7. PubMed ID: 11600577
[TBL] [Abstract][Full Text] [Related]
42. Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice.
Chojnacka-Wójcik E; Kłodzińska A; Dereń-Wesołek A
Pol J Pharmacol; 1994; 46(5):423-8. PubMed ID: 7894529
[TBL] [Abstract][Full Text] [Related]
43. Effect of prolonged administration of the serotonin4 (5-HT4) receptor agonist cisapride on aldosterone secretion in healthy volunteers.
Lefebvre H; Gonzalez KN; Contesse V; Delarue C; Vaudry H; Kuhnl JM
Endocr Res; 1998; 24(3-4):749-52. PubMed ID: 9888571
[TBL] [Abstract][Full Text] [Related]
44. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
[TBL] [Abstract][Full Text] [Related]
45. Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines.
Neri G; Andreis PG; Prayer-Galetti T; Rossi GP; Malendowicz LK; Nussdorfer GG
J Clin Endocrinol Metab; 1996 Jan; 81(1):169-73. PubMed ID: 8550747
[TBL] [Abstract][Full Text] [Related]
46. Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
Stern N; Eggena P; Chandler W; Tuck ML
Am J Physiol; 1989 Oct; 257(4 Pt 1):E588-94. PubMed ID: 2679132
[TBL] [Abstract][Full Text] [Related]
47. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro.
Feelders RA; Lamberts SW; Hofland LJ; van Koetsveld PM; Verhoef-Post M; Themmen AP; de Jong FH; Bonjer HJ; Clark AJ; van der Lely AJ; de Herder WW
J Clin Endocrinol Metab; 2003 Jan; 88(1):230-7. PubMed ID: 12519858
[TBL] [Abstract][Full Text] [Related]
48. Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor.
Villalón CM; den Boer MO; Heiligers JP; Saxena PR
Br J Pharmacol; 1990 Aug; 100(4):665-7. PubMed ID: 2207493
[TBL] [Abstract][Full Text] [Related]
49. Cerebellin enhances in vitro secretory activity of human adrenal gland.
Mazzocchi G; Andreis PG; De Caro R; Aragona F; Gottardo L; Nussdorfer GG
J Clin Endocrinol Metab; 1999 Feb; 84(2):632-5. PubMed ID: 10022429
[TBL] [Abstract][Full Text] [Related]
50. Prevention and treatment of the gastric symptoms of radiation sickness.
Dubois A; Fiala N; Boward CA; Bogo V
Radiat Res; 1988 Sep; 115(3):595-604. PubMed ID: 3174940
[TBL] [Abstract][Full Text] [Related]
51. SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae.
Yang DC; Goldstin B; Moormann AE; Flynn DL; Gullikson GW
J Pharmacol Exp Ther; 1993 Sep; 266(3):1339-47. PubMed ID: 8396633
[TBL] [Abstract][Full Text] [Related]
52. The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists.
Barnes JM; Barnes NM; Costall B; Domeney AM; Johnson DN; Kelly ME; Munson HR; Naylor RJ; Young R
Pharmacol Biochem Behav; 1990 Dec; 37(4):717-27. PubMed ID: 2128757
[TBL] [Abstract][Full Text] [Related]
53. Studies on the emetic and antiemetic properties of zacopride and its enantiomers.
Sancilio LF; Pinkus LM; Jackson CB; Munson HR
Eur J Pharmacol; 1991 Jan; 192(3):365-9. PubMed ID: 2055236
[TBL] [Abstract][Full Text] [Related]
54. Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride.
Barnes NM; Costall B; Ironside JW; Naylor RJ
J Pharm Pharmacol; 1988 Sep; 40(9):668. PubMed ID: 2907045
[No Abstract] [Full Text] [Related]
55. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
Young R; Johnson DN
Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
[TBL] [Abstract][Full Text] [Related]
56. Stereoselective effects of (R)- and (S)-zacopride on cognitive performance in a spatial navigation task in rats.
Fontana DJ; Daniels SE; Eglen RM; Wong EH
Neuropharmacology; 1996 Mar; 35(3):321-7. PubMed ID: 8783207
[TBL] [Abstract][Full Text] [Related]
57. 5-HT receptor subtypes involved in luminal serotonin-induced secretion in rat intestine in vivo.
Hansen MB; Jaffe BM
J Surg Res; 1994 Mar; 56(3):277-87. PubMed ID: 8145546
[TBL] [Abstract][Full Text] [Related]
58. Effects of adrenomedullin on the human adrenal glands: an in vitro study.
Andreis PG; Neri G; Prayer-Galetti T; Rossi GP; Gottardo G; Malendowicz LK; Nussdorfer GG
J Clin Endocrinol Metab; 1997 Apr; 82(4):1167-70. PubMed ID: 9100590
[TBL] [Abstract][Full Text] [Related]
59. Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism.
Zeng ZP; Naruse M; Guan BJ; Naruse K; Sun ML; Zang MF; Demura H; Shi YF
J Clin Endocrinol Metab; 1992 Apr; 74(4):874-8. PubMed ID: 1548353
[TBL] [Abstract][Full Text] [Related]
60. The variability in oro-cecal transit time assessed using a bean-based test meal and its use in the study of the effect of metoclopramide and BRL 24924 on transit time.
Staniforth DH; Rose D
Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):97-101. PubMed ID: 2722310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
